See more : 63 Moons Technologies Limited (63MOONS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of DIVA Laboratories, Ltd. (4153.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DIVA Laboratories, Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Lifeist Wellness Inc. (LFST.V) Income Statement Analysis – Financial Results
- Unique Opto-Electronics Co.,Ltd. (3441.TWO) Income Statement Analysis – Financial Results
- Team Precision Public Company Limited (TEAM.BK) Income Statement Analysis – Financial Results
- The Glimpse Group, Inc. (VRAR) Income Statement Analysis – Financial Results
- Formcap Corp. (FRMC) Income Statement Analysis – Financial Results
DIVA Laboratories, Ltd. (4153.TWO)
About DIVA Laboratories, Ltd.
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. The company provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays/human machine interface products; medical and industrial cases; and displays to ODM and OEM customers. It also offers video solutions. The company was incorporated in 1995 and is headquartered in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 893.84M | 949.20M | 712.23M | 736.93M | 716.17M |
| Cost of Revenue | 643.07M | 683.07M | 530.64M | 523.26M | 491.33M |
| Gross Profit | 250.77M | 266.13M | 181.60M | 213.66M | 224.84M |
| Gross Profit Ratio | 28.06% | 28.04% | 25.50% | 28.99% | 31.39% |
| Research & Development | 69.03M | 82.62M | 69.52M | 61.58M | 63.42M |
| General & Administrative | 48.08M | 48.91M | 48.59M | 48.84M | 52.44M |
| Selling & Marketing | 36.93M | 48.79M | 39.59M | 34.26M | 41.75M |
| SG&A | 88.28M | 97.70M | 88.18M | 83.10M | 94.20M |
| Other Expenses | 1.32M | 7.93M | 11.15M | 8.59M | 4.15M |
| Operating Expenses | 158.62M | 180.32M | 157.69M | 144.68M | 159.07M |
| Cost & Expenses | 801.69M | 863.39M | 688.33M | 667.95M | 650.40M |
| Interest Income | 0.00 | 761.00K | 533.00K | 3.65M | 8.36M |
| Interest Expense | 0.00 | 201.00K | 110.00K | 57.00K | 1.00K |
| Depreciation & Amortization | 8.17M | 10.10M | 13.71M | 19.04M | 19.46M |
| EBITDA | 100.32M | 132.28M | 38.40M | 77.72M | 84.06M |
| EBITDA Ratio | 11.22% | 13.94% | 5.39% | 10.55% | 11.74% |
| Operating Income | 92.15M | 122.18M | 24.69M | 58.69M | 64.60M |
| Operating Income Ratio | 10.31% | 12.87% | 3.47% | 7.96% | 9.02% |
| Total Other Income/Expenses | -4.38M | -17.19M | 3.70M | -42.98M | 72.00K |
| Income Before Tax | 87.77M | 67.64M | 28.47M | 27.56M | 65.45M |
| Income Before Tax Ratio | 9.82% | 7.13% | 4.00% | 3.74% | 9.14% |
| Income Tax Expense | 14.15M | 17.98M | 6.61M | 10.14M | 9.41M |
| Net Income | 73.62M | 49.66M | 21.86M | 17.42M | 56.04M |
| Net Income Ratio | 8.24% | 5.23% | 3.07% | 2.36% | 7.83% |
| EPS | 1.25 | 0.85 | 0.37 | 0.26 | 0.78 |
| EPS Diluted | 1.25 | 0.84 | 0.37 | 0.26 | 0.78 |
| Weighted Avg Shares Out | 58.89M | 58.67M | 58.67M | 66.44M | 72.03M |
| Weighted Avg Shares Out (Dil) | 58.90M | 58.83M | 58.79M | 66.57M | 72.20M |
Source: https://incomestatements.info
Category: Stock Reports